Top Markets
#1 The Black Bull The Black Bull +22.59%
#2 EXOD EXOD +22.08%
#3 SSV Network SSV Network +21.25%
#4 XPIN Network XPIN Network +21.09%
#5 Useless Coin Useless Coin +20.60%
#6 Ore Ore +20.14%
#7 GALA GALA +19.48%
#8 Wrapped XPL Wrapped XPL +18.69%
#9 Plasma Plasma +18.68%
#10 Unit Plasma Unit Plasma +18.68%
Coin of the day
The Black Bull The Black Bull
Settings
Language
ENGLISH
Currency
USD
Theme
Advagene Biopharma Co., Ltd. Advagene Biopharma Co., Ltd.

Advagene Biopharma Co., Ltd.

6709
Rank in Stocks #24966
Based in Taipei, Taiwan, Advagene Biopharma Co., Ltd. is a firm dedicated to... Based in Taipei, Taiwan, Advagene Biopharma Co., Ltd. is a firm dedicated to pioneering advancements in vaccine science and associated medical solutions. Its current development portfolio comprises a nasal spray vaccine for influenza, various allergy-specific vaccines, and an immunotherapy targeting COVID-19.
Share Price
$0.79974555
Market Cap
$54.69M
Change (1 day)
-4.73%
Change (1 year)
11.75%
Country
TW
Trade Advagene Biopharma Co., Ltd. (6709)

Category

Healthcare
P/E ratio for Advagene Biopharma Co., Ltd. (6709)
P/E ratio as of 2026 TTM: 0
According to Advagene Biopharma Co., Ltd. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Advagene Biopharma Co., Ltd. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.